Cargando…

Inhibition of Tumor Necrosis Factor‐α and β Secretion by Lymphokine Activated Killer Cells by Transforming Growth Factor‐β

Transforming growth factor‐β (TGF‐β) has a variety of immunosuppressive properties. We investigated the effect of TGF‐β secreted by glioblastoma (T98G) cells on the secretion of tumor necrosis factor‐α and ‐β (TNFs) by lymphokine activated killer (LAK) cells stimulated with tumor cells. The supernat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naganuma, Hirofumi, Sasaki, Atsushi, Satoh, Eiji, Nagasaka, Mitsuyasu, Nakano, Shin, Isoe, Shiro, Tasaka, Kachio, Nukui, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1994
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919594/ https://www.ncbi.nlm.nih.gov/pubmed/7961125 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02974.x

Ejemplares similares

Expression of Membrane‐associated Lymphotoxin/Tumor Necrosis Factor‐β on Human Lymphokine‐activated Killer Cells
por: Abe, Yasuhito, et al.
Publicado: (1991)

Characterization of Transendothelial Migratory Lymphokine‐activated Killer Cells
por: Nakano, Koji, et al.
Publicado: (1996)

Augmentation by Tumor Necrosis Factor α of the Systemic Therapeutic Effect of Lymphokine‐activated Killer Cells in Adoptive Immunotherapy of Murine Tumor
por: Kato, Kazunori, et al.
Publicado: (1991)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Lymphokine-activated killer cells. Analysis of progenitors and effectors
Publicado: (1986)

Stimulation of Macrophages with the β-Glucan Produced by Aureobasidium pullulans Promotes the Secretion of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL)
por: Kawata, Koji, et al.
Publicado: (2015)

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
Publicado: (1983)

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
por: Vaz, F., et al.
Publicado: (1995)

Induction of lymphokine-activated killer-like cells by cancer chemotherapy
Publicado: (1988)

Establishment of Mouse Lymphokine‐activated Killer Cell Clones and Their Properties
por: Kato, Kazunori, et al.
Publicado: (1991)

The Heterogeneity of Target Recognition by Lymphokine‐activated Killer Precursor Cells
por: Ibayashi, Yukihiro, et al.
Publicado: (1990)

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
Publicado: (1988)

IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
por: Yamaki, Toshiaki, et al.
Publicado: (1988)

Lymphokines
por: Hamblin, Anne S
Publicado: (1998)

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
Publicado: (1991)

Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
Publicado: (1989)

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
por: West, E J, et al.
Publicado: (2011)

Enhancing Effect of Pokeweed Mitogen on the Proliferation and the Cytotoxicity of Lymphokine‐activated Killer Cells
por: Kimoto, Yasuhiko, et al.
Publicado: (1992)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis
Publicado: (1986)

Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii
Publicado: (1992)

Influence of transfusion of lymphokine-activated T killer cells on inflammatory responses in dogs after laparotomy
por: MIE, Keiichiro, et al.
Publicado: (2016)

Generation and Characterization of Lymphokine‐activated Killer Cells against Fresh Human Leukemia Cells
por: Tahara, Tohru, et al.
Publicado: (1988)

Two Populations of Mouse Lymphokine‐activated Killer Cells Separated by Use of Soybean Agglutinin
por: Takano, Mariko, et al.
Publicado: (1989)

T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma
por: Quan, Chuntao, et al.
Publicado: (2017)

Killing of Alveolar Macrophages and of Monocytes that Have Responded to Granulocyte‐Macrophage Colony‐stimulating Factor by Human Lymphokine‐activated Killer Cells
por: Sone, Saburo, et al.
Publicado: (1989)

Transfection‐induced Tumor Necrosis Factor‐α Increases the Susceptibility of Human Glioma Cells to Lysis by Lymphokine‐activated Killer Cells: Continuous Expression of Intercellular Adhesion Molecule‐1 on the Glioma Cells
por: Takaoka, Toru, et al.
Publicado: (1994)

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
Publicado: (1989)

Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995)

Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness
Publicado: (1987)

Augmentation of Murine Lymphokine‐activated Killer Cell Induction by a Factor Produced by Nocardia rubra Cell Wall Skeleton‐stimulated T Cells
por: Kawase, Ichiro, et al.
Publicado: (1989)

Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
por: Savas, Burhan, et al.
Publicado: (2006)

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
por: Böhm, M., et al.
Publicado: (1994)

T Cell Receptor‐independent Cell‐mediated Cytotoxicity by Nude Mouse Lymphokine‐activated Killer Cells
por: Nishimura, Takashi, et al.
Publicado: (1991)

Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats
por: Maeta, Noritaka, et al.
Publicado: (2019)

Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells
por: Aguilar Díaz de león, Jesús S, et al.
Publicado: (2021)

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
por: Foreman, N. K., et al.
Publicado: (1993)

An arthritogenic lymphokine in the rat
Publicado: (1985)

The First α Helix of Interleukin (Il)-2 Folds as a Homotetramer, Acts as an Agonist of the IL-2 Receptor β Chain, and Induces Lymphokine-Activated Killer Cells
por: Eckenberg, Ralph, et al.
Publicado: (2000)

Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model.
por: Eggermont, A. M., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_lc6bjne888gu0scid0gc9nmrbc